Universal directly observed therapy. A treatment strategy for tuberculosis

Area of Science:

• Public Health
• Infectious Diseases
• Health Services Research

Background:

• Patient adherence to tuberculosis (TB) regimens is critical to prevent treatment failure, drug resistance, and ongoing transmission.
• Directly Observed Therapy (DOT) is an effective strategy to ensure adherence but is often perceived as prohibitively expensive.
• The widespread adoption of DOT is hindered by cost concerns, limiting its use in TB management.

Purpose of the Study:

• To evaluate the cost-effectiveness and implementation of universal DOT compared to selective DOT for tuberculosis patients.
• To address the perception of high costs associated with DOT and explore its broader application.
• To provide guidelines for implementing DOT strategies in tuberculosis treatment programs.

Main Methods:

• The article focuses on a policy analysis of universal versus selective DOT strategies.
• It examines factors including cost, treatment efficacy, patient nonadherence, and practical implementation guidelines.
• The study contrasts the implications of observing all patients versus a selected group.

Main Results:

• Universal DOT, despite perceived costs, can be a cost-effective strategy for tuberculosis management.
• Ensuring adherence through DOT is vital for preventing TB relapse, acquired resistance, and transmission.
• Implementation guidelines are discussed to facilitate the adoption of DOT programs.

Conclusions:

• Universal DOT is a viable and potentially cost-effective strategy for comprehensive tuberculosis control.
• Addressing cost perceptions and focusing on implementation are key to expanding DOT use.
• DOT remains a cornerstone for ensuring treatment success and preventing public health crises related to tuberculosis.